Breathing Muscle Training for Scleroderma
Part of Skin clinical trials.
This study tests whether a special breathing exercise program can strengthen the muscles you use to breathe. It is for people with scleroderma (a condition that can affect the lungs and tissues) to see if these exercises improve breathing and quality of life.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old.
- You have been diagnosed with scleroderma.
- Your medications for scleroderma have not changed in the last 3 months.
- You are willing and able to follow the study instructions.
- You can read and write.
- You do not have any other serious health problems like cancer, pregnancy, or conditions that make exercise hard.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests if a special exercise program based on your body and mind can help people with scleroderma feel better. It is for both children (ages 7-18) and adults.
This study looks at how scleroderma affects breathing muscles and exercise ability. You'll do some simple breathing tests and ride a stationary bike to see how your body responds.
This study looks at whether people with systemic sclerosis (scleroderma) have weakness in the muscles they use to breathe. It aims to find out if measuring these muscles can help detect early breathing problems.
This study tests if special breathing exercises can help people with multiple sclerosis. You will do exercises to strengthen the muscles you use to breathe, and researchers will see if it improves your breathing and daily function.
This trial tests if special breathing exercises can help teens with scoliosis who are also doing Schroth therapy. It aims to strengthen the muscles that help you breathe.
This study tests whether strengthening your breathing muscles with a special device can improve your breathing and daily function. It is for people with chronic heart failure who are stable on their current medications and have not been hospitalized recently.
Hear when a new Scleroderma (Limited and Diffuse) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.